Paul D. Leeson

Statistics

Publications

Citations

7.8K

H-Index

Active since

1976

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Loughborough University

AstraZeneca (United Kingdom)

Paul D. Leeson is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and neuropharmacology.

ORCID

Publications per year

1976–2024

Publications

The Design of Leadlike Combinatorial Libraries

Simon J. Teague, A. M. Davis, Paul D. Leeson et al. · Angewandte Chemie International Edition · 1999 · 810 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Is There a Difference between Leads and Drugs? A Historical Perspective

Tudor I. Oprea, A. M. Davis, Simon J. Teague et al. · Journal of Chemical Information and Computer Sciences · 2001 · 775 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs

Mark C. Wenlock, Rupert P. Austin, Patrick Barton et al. · Journal of Medicinal Chemistry · 2003 · 537 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex.

John A. Kemp, Alan C. Foster, Paul D. Leeson et al. · Proceedings of the National Academy of Sciences · 1988 · 521 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Time-Related Differences in the Physical Property Profiles of Oral Drugs

Paul D. Leeson, A. M. Davis · Journal of Medicinal Chemistry · 2004 · 325 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

1–5 of 82